Search

Search Constraints

You searched for: Issue Volume 114(2022)

Search Results

533. Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience. (March 2022)